Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)

ClinicalTrials.gov ID: NCT02854605

Public ClinicalTrials.gov record NCT02854605. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 9:40 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Nonalcoholic Steatohepatitis (NASH)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to evaluate the safety and tolerability of GS-9674 in participants with nonalcoholic steatohepatitis (NASH).

Study identification

NCT ID
NCT02854605
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gilead Sciences
Industry
Enrollment
140 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 25, 2016
Primary completion
Jan 8, 2018
Completion
Jan 8, 2018
Last update posted
Jan 28, 2019

2016 – 2018

United States locations

U.S. sites
26
U.S. states
14
U.S. cities
22
Facility City State ZIP Site status
Ruane Clinical Research Group Inc. Los Angeles California 90036
Cedars Sinai Medical Center Los Angeles California 90048
Inland Empire Liver Foundation Rialto California 92377
Clinical Research of South Florida Coral Gables Florida 33134
Atlanta Gastroenterology Associates Atlanta Georgia 30308
Northwestern Memorial Hospital, Clinical Research Unit Chicago Illinois 60611
Crescent Clinical Research Center, LLC Metairie Louisiana 70006
Tulane University Health Sciences Center New Orleans Louisiana 70112
Kansas City Research Institute Kansas City Missouri 64131
Concorde Medical Group, PLLC New York New York 10016
Duke University Medical Center, Duke South Clinics Durham North Carolina 27710
Carolinas Center for Liver Disease/Carolinas HealthCare System Durham North Carolina 28078
Thomas Jefferson University Philadelphia Pennsylvania 19107
Gastro One Germantown Tennessee 38138
Quality Medical Research, PC Nashville Tennessee 37211
Texas Clinical Research Institute Arlington Texas 76012
The Liver Institute at Methodist Dallas Medical Center Dallas Texas 75203
Texas Digestive Disease Consultants Dallas Texas 75246
Houston Methodist Hospital Houston Texas 77030
Pinnacle Clinical Research Live Oak Texas 78233
American Research Corporation at the Texas Liver Institute San Antonio Texas 78215
Intermountain Liver Disease and Transplant Center Murray Utah 84107
Bon Secours St. Mary's Hospital of Richmond, Inc d/b/a Bon Secours Liver Institute of Virginia Newport News Virginia 23602
Bon Secours St. Mary's Hospital of Richmond, Inc. d/b/a Bon Secours Liver Institute of Virginia Richmond Virginia 23226
McGuire VA Medical Center Richmond Virginia 23249
Swedish Organ Transplant and Liver Center Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02854605, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 28, 2019 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02854605 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →